Novartis Hits Spartalizumab Phase III Setback In Melanoma

IO MAPK Inhibitor Combination Hopes Dashed

 
• By Alexandra Shimmings
Melanoma_Magnified
• Source: Shutterstock

More from Business

More from Scrip